Genmab A (GMAB) FCF Margin (2018 - 2026)

Genmab A has reported FCF Margin for 6 years, with the latest figure at 0.33% in Q1 2026.

• For the quarter ending Q1 2026, FCF Margin fell 3981.0% year-over-year to 0.33%; the trailing twelve-month figure through Mar 2026 stood at 24.96% (down 1019.0% YoY), and the FY2025 full-year result was 30.89%, down 433.0% from the prior year.
• FCF Margin for Q1 2026 stood at 0.33%, down from 52.45% in the prior quarter.
• The five-year high for FCF Margin was 56.23% in Q2 2024, with the low at 0.33% in Q1 2026.
• Historically, FCF Margin has averaged 37.12% across 3 years, with a median of 37.73% in 2025.
• Annual changes were most pronounced in 2025 — FCF Margin surged 1580 bps — and 2026, when it slumped 3981 bps.
• Genmab A's FCF Margin stood at 36.64% in 2024, then surged by 43 bps to 52.45% in 2025, then plunged by 99 bps to 0.33% in 2026.
• The last three FCF Margin figures came in at 0.33% (Q1 2026), 52.45% (Q3 2025), and 37.73% (Q2 2025), per Business Quant data.